Solar roof for Gerresheimer/Triveni Plant
Düsseldorf/Kundli, September 05, 2016 – Being the leading global partner for the pharmaceutical and healthcare industries, Gerresheimer is committed to sustainability and environmental protection. The majority of Triveni Polymers in Kundli (India) belongs to the Gerresheimer Group since 2012. In order to meet its environmental and sustainability objectives the company put a photovoltaic system into operation to enable the production of pharmaceutical plastic packaging with environmental-friendly energy.
“We are proud to contribute to a “greener planet. Sustainability is one of our company’s priority objectives, said Subodh Gupta, Managing Director at Triveni and the person in charge of the whole project. Subodh is also responsible for energy costs, ”
As a start 80 solar panels have been installed with a capacity of 20 KW. In addition to the environment benefits Triveni will significantly reduce the monthly electricity expenses.
In the future Triveni is planning to install more panels and the target is to reach a level where at least 3 % of the total requirement of electricity is met by the use of solar energy. Gerresheimer/Triveni is aiming for 100 KW of solar power in the future.
With clearly defined objectives, the entire Gerresheimer Group is taking part in one of the world’s biggest environmental initiatives, the Carbon Disclosure Project. This non-profit organization was founded in London, UK. It checks and monitors greenhouse emissions of companies on a worldwide basis and also identifies the strategies companies implement in response to climate change.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products the company contributes to health and well-being. Gerresheimer has worldwide operations and its 11,000 employees manufacture products in local markets, close to its customers. With over 40 plants in Europe, North America, South America and Asia, Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe and simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.